MarketBeat Instant News Alerts 2 hours agoAmerican Financial Group (NYSE:AFG) Stock Price Target Lowered at Keefe, Bruyette & WoodsMarketBeatKeefe, Bruyette & Woods dropped their price target on shares of American Financial Group from $153.00 to $147.00 and set a "market perform" rating on the stock in a research note on Monday.NYSE:AFGRead American Financial Group (NYSE:AFG) Stock Price Target Lowered at Keefe, Bruyette & Woods2 hours agoKeefe, Bruyette & Woods Issues Pessimistic Forecast for American International Group (NYSE:AIG) Stock PriceMarketBeatKeefe, Bruyette & Woods dropped their target price on American International Group from $96.00 to $90.00 and set an "outperform" rating for the company in a research report on Monday.NYSE:AIGRead Keefe, Bruyette & Woods Issues Pessimistic Forecast for American International Group (NYSE:AIG) Stock Price2 hours agoAmerican Integrity Insurance Group (NYSE:AII) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst SaysMarketBeatKeefe, Bruyette & Woods raised their price objective on shares of American Integrity Insurance Group from $29.00 to $31.00 and gave the stock an "outperform" rating in a report on Monday.NYSE:AIIRead American Integrity Insurance Group (NYSE:AII) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says2 hours agoArch Capital Group (NASDAQ:ACGL) Stock Price Target Lowered at Keefe, Bruyette & WoodsMarketBeatKeefe, Bruyette & Woods reduced their price objective on Arch Capital Group from $99.00 to $95.00 and set a "market perform" rating for the company in a report on Monday.NASDAQ:ACGLRead Arch Capital Group (NASDAQ:ACGL) Stock Price Target Lowered at Keefe, Bruyette & Woods2 hours agoConnect Biopharma (NASDAQ:CNTB) Stock Rating Reaffirmed as Outperform by Leerink PartnersMarketBeatLeerink Partners restated an "outperform" rating and set a $4.00 price target on shares of Connect Biopharma in a research report on Monday.NASDAQ:CNTBRead Connect Biopharma (NASDAQ:CNTB) Stock Rating Reaffirmed as Outperform by Leerink Partners2 hours agoEquillium (NASDAQ:EQ) Given "Outperform" Rating at Leerink PartnersMarketBeatLeerink Partners reiterated an "outperform" rating and issued a $6.00 price objective on shares of Equillium in a report on Monday.NASDAQ:EQRead Equillium (NASDAQ:EQ) Given "Outperform" Rating at Leerink Partners Trending News1223,354 Shares in USA Rare Earth Inc. $USAR Purchased by Overbrook Management Corp2Stock Traders Purchase High Volume of Almonty Industries Call Options (NASDAQ:ALM)3IREN (NASDAQ:IREN) Stock Falls 7.7% - Should You Sell?4GameStop (NYSE:GME) Stock Sees Heavy Call Option Buying5AST SpaceMobile (NASDAQ:ASTS) Shares Gap Down - Should You Sell?6Rocket Lab (NASDAQ:RKLB) Shares Down 4.2% - Here's Why7Eos Energy Enterprises (NASDAQ:EOSE) Stock Price Down 5.6% - Here's What Happened8Amazon.com (NASDAQ:AMZN) Stock Price Up 3.3% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoNektar Therapeutics (NASDAQ:NKTR) Now Covered by Leerink PartnersMarketBeatNASDAQ:NKTRRead Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Leerink Partners2 hours agoLeerink Partners Begins Coverage on Q32 Bio (NASDAQ:QTTB)MarketBeatNASDAQ:QTTBRead Leerink Partners Begins Coverage on Q32 Bio (NASDAQ:QTTB)2 hours agoLeerink Partners Begins Coverage on Vera Therapeutics (NASDAQ:VERA)MarketBeatNASDAQ:VERARead Leerink Partners Begins Coverage on Vera Therapeutics (NASDAQ:VERA)2 hours agoEnovix (NASDAQ:ENVX) Announces Q3 2026 Earnings GuidanceMarketBeatNASDAQ:ENVXRead Enovix (NASDAQ:ENVX) Announces Q3 2026 Earnings Guidance2 hours agoBiogen (NASDAQ:BIIB) Stock Bumped Up to "Overweight" by JPMorgan Chase & Co.MarketBeatNASDAQ:BIIBRead Biogen (NASDAQ:BIIB) Stock Bumped Up to "Overweight" by JPMorgan Chase & Co.2 hours agoRobert W. Baird Has Lowered Expectations for WillScot (NASDAQ:WSC) Stock PriceMarketBeatNASDAQ:WSCRead Robert W. Baird Has Lowered Expectations for WillScot (NASDAQ:WSC) Stock Price2 hours agoBRAEMAR HOTELS & RESORTS (NYSE:BHR) Given New $2.00 Price Target at Robert W. BairdMarketBeatNYSE:BHRRead BRAEMAR HOTELS & RESORTS (NYSE:BHR) Given New $2.00 Price Target at Robert W. Baird2 hours agoVisa (NYSE:V) Given New $430.00 Price Target at Robert W. BairdMarketBeatNYSE:VRead Visa (NYSE:V) Given New $430.00 Price Target at Robert W. Baird2 hours agoKimball Electronics, Inc. (KE) - What Are Analysts Saying About This Stock?MarketBeatNASDAQ:KERead Kimball Electronics, Inc. (KE) - What Are Analysts Saying About This Stock?2 hours agoBTIG Research Has Lowered Expectations for Medtronic (NYSE:MDT) Stock PriceMarketBeatNYSE:MDTRead BTIG Research Has Lowered Expectations for Medtronic (NYSE:MDT) Stock Price2 hours agoBTIG Research Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock PriceMarketBeatNASDAQ:ISRGRead BTIG Research Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price2 hours agoBTIG Research Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockMarketBeatNYSE:GKOSRead BTIG Research Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock2 hours agoBTIG Research Issues Pessimistic Forecast for GE HealthCare Technologies (NASDAQ:GEHC) Stock PriceMarketBeatNASDAQ:GEHCRead BTIG Research Issues Pessimistic Forecast for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price2 hours agoDexCom (NASDAQ:DXCM) Stock Price Expected to Rise, BTIG Research Analyst SaysMarketBeatNASDAQ:DXCMRead DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, BTIG Research Analyst Says2 hours agoCarlsmed (NASDAQ:CARL) Price Target Raised to $24.00MarketBeatNASDAQ:CARLRead Carlsmed (NASDAQ:CARL) Price Target Raised to $24.002 hours agoAvita Medical (NASDAQ:RCEL) Stock Gets Price Target Increase from BTIG ResearchMarketBeatNASDAQ:RCELRead Avita Medical (NASDAQ:RCEL) Stock Gets Price Target Increase from BTIG Research2 hours agoBTIG Research Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) StockMarketBeatNASDAQ:ATRCRead BTIG Research Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock2 hours agoAardvark Therapeutics (NASDAQ:AARD) Stock Keeps "Neutral" Rating at BTIG ResearchMarketBeatNASDAQ:AARDRead Aardvark Therapeutics (NASDAQ:AARD) Stock Keeps "Neutral" Rating at BTIG Research2 hours agoNeedham & Company LLC Forecasts Strong Price Appreciation for Synopsys (NASDAQ:SNPS) StockMarketBeatNASDAQ:SNPSRead Needham & Company LLC Forecasts Strong Price Appreciation for Synopsys (NASDAQ:SNPS) Stock2 hours agoHub Group (NASDAQ:HUBG) Raised to Outperform at Robert W. BairdMarketBeatNASDAQ:HUBGRead Hub Group (NASDAQ:HUBG) Raised to Outperform at Robert W. Baird2 hours agoEndava (NYSE:DAVA) Earns Buy Rating from Needham & Company LLCMarketBeatNYSE:DAVARead Endava (NYSE:DAVA) Earns Buy Rating from Needham & Company LLC2 hours agoBTIG Research Forecasts Strong Price Appreciation for Shoulder Innovations (NYSE:SI) StockMarketBeatNYSE:SIRead BTIG Research Forecasts Strong Price Appreciation for Shoulder Innovations (NYSE:SI) Stock2 hours agoStryker (NYSE:SYK) Stock Gets Price Target Reduction from BTIG ResearchMarketBeatNYSE:SYKRead Stryker (NYSE:SYK) Stock Gets Price Target Reduction from BTIG Research2 hours agoTactile Systems Technology (NASDAQ:TCMD) Stock Gets Price Target Trim from BTIG ResearchMarketBeatNASDAQ:TCMDRead Tactile Systems Technology (NASDAQ:TCMD) Stock Gets Price Target Trim from BTIG Research Featured Articles and OffersWant Private-Market Access to Kalshi and Polymarket? Try This ETFBy Jessica Mitacek | October 8, 2026How options let you do more with less capitalFrom Base Camp Trading (Ad)NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunBy Thomas Hughes | October 5, 2026DraftKings Stacks the Deck: The $800M Prediction PivotBy Jeffrey Neal Johnson | October 7, 20263 Stocks Chopped in Half: Why These Drops May Be Structural, Not a DipBy Dan Schmidt | October 11, 2026Elon Musk’s Hushed FCC Filing. Dec 8th.From Paradigm Press (Ad)Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AIBy Chris Markoch | October 6, 2026Skydance Just Became a Media Giant—With an $80 Billion Debt LoadBy Dan Schmidt | October 7, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 203 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
